Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mark A. Marzinke"'
Autor:
Sharon L. Achilles, Peter A. Anton, Nicola Richardson-Harman, Ross D Cranston, Jarret Engstrom, Kaleab Z. Abebe, Sylvain Chawki, Hans M. L. Spiegel, Beatrice A. Chen, Craig W. Hendrix, Cindy Jacobson, Aaron Siegel, Mark A. Marzinke, Lisa C. Rohan, Alex Reinhart, John Steytler, Ron Stall, Elena Khanukova, Ian McGowan, Rhonda M. Brand
Publikováno v:
AIDS Res Hum Retroviruses
The Combination HIV Antiretroviral Rectal Microbicide-3 (CHARM-03) study was a randomized, open-label, crossover Phase 1 safety and pharmacokinetic (PK) study of oral maraviroc (MVC) and MVC 1% gel. At a single site, healthy HIV-uninfected men and wo
Autor:
Jill L. Schwartz, Timothy H. Holtz, Ian McGowan, Craig W. Hendrix, Marcel E. Curlin, Mark A. Marzinke, Gustavo F. Doncel, Ratiya Pamela Kunjara Na Ayudhya, Rhonda M. Brand, James F. Rooney, Boonyos Raengsakulrach, Anupong Chitwarakorn, Ross D Cranston, Jeanna M. Piper, Sherri Johnson
Publikováno v:
AIDS Res Hum Retroviruses
The Microbicide Trials Network-017 study was undertaken to characterize the safety, acceptability, pharmacokinetic (PK), and pharmacodynamic profile of the reduced-glycerin (RG) 1% tenofovir (RG-TFV) gel compared to oral emtricitabine/tenofovir disop
Autor:
Craig W. Hendrix, Fernand Guédou, Souleymane Diabaté, Marie-Pierre Gagnon, Moussa Bachabi, Michel Alary, Flore Gangbo, Mark A. Marzinke, Luc Béhanzin, Aminata Mboup, Djimon Marcel Zannou, René K Kêkê
Publikováno v:
Sexually Transmitted Diseases
A study of demographic and behavioral factors found that older age, high intention, and shorter duration of preexposure prophylaxis use were associated with higher preexposure prophylaxis adherence among Beninese female sex workers.
Background H
Background H
Autor:
Maoji Li, Mark A. Marzinke, Bonnie J. Dye, James P. Hughes, Timothy H. Holtz, Craig W. Hendrix, K. Rivet Amico, Anupong Chitwarakorn, Ethan Wilson, Sharon Mannheimer, Linda-Gail Bekker, Victoria D. Ojeda, Robert M. Grant
Publikováno v:
J Acquir Immune Defic Syndr
We evaluated the relationship between 2 types of social relationships, ie, (1) external support for use of HIV pre-exposure prophylaxis (PrEP) and related study supplies and (2) participants' disclosure of PrEP use and condom use and HIV PrEP adheren
Autor:
Charlene S. Dezzutti, Devika Singh, Melissa Peda, Mark A. Marzinke, Clara Dominguez, Craig W. Hendrix, Jeremy Nuttall, Ryan C Tingler, Brid Devlin, Jeanna M. Piper, Elizabeth R. Brown, Jonathan Lucas, José A. Bauermeister, Ken K. Y. Ho, Sherri Johnson, Mtn Protocol Team, Ratiya Pamela Kunjara Na Ayudhya, Ian McGowan, Lindsay F. Kramzer, Cindy Jacobson, Holly Gundacker, Nicole Macagna, Ross D Cranston, Eileen F. Dunne, Craig J. Hoesley
Publikováno v:
AIDS Behav
This study describes the acceptability of a rectal microbicide gel formulation using dapivirine (DPV) among men and women from two countries (United States and Thailand) participating in the Microbicide Trials Network-026 trial. We evaluated particip
Autor:
Philip Sullivan, Adeola Adeyeye, Jeanne M. Marrazzo, James F. Rooney, David J. Margolis, Susan H. Eshleman, Jonathan Lucas, Suwat Chariyalertsak, Ha V Tran, Peter J. Anderson, Hyman M. Scott, Eric S. Daar, Nittaya Phanuphak, Beatriz Grinsztejn, Colleen F Kelley, Craig W. Hendrix, Jorge A Gallardo-Cartagena, J Valdez Madruga, Sheldon D. Fields, Aditya H Gaur, Joseph J. Eron, Myron S. Cohen, Christina Psaros, Paul G. Richardson, Kailazarid Gomez-Feliciano, Zhe Wang, Meredith E. Clement, Timothy H. Holtz, Alex R. Rinehart, Aida Asmelash, Steven A. Safren, Lara E. Coelho, Juan C Hinojosa, Roy M. Gulick, Hptn (PopART) Study Team, Eileen F. Dunne, Andrea Jennings, Javier Valencia Huamaní, Pedro Gonzales, Shobha Swaminathan, Kimberly Y. Smith, Estelle Piwowar-Manning, Deborah Donnell, Marcelo H. Losso, Marcus Bryan, Ryan Kofron, Esper G Kallas, Brett Hanscom, Leslie Cottle, Marybeth McCauley, Jeremy Sugarman, Carlos del Rio, Raphael J. Landovitz, Robinson Cabello, William Spreen, Cheryl Blanchette, Edgar T. Overton, Omar Sued, Katherine Shin, Maoji Li, Keren Middelkoop, Nirupama Sista, Mark A. Marzinke, Breno Santos, Ian Frank, Todd T. Brown
Publikováno v:
The New England journal of medicine, vol 385, iss 7
BackgroundSafe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection.MethodsWe conducted a randomized, double-bl
Autor:
Anthony S. Ham, Karen W. Buckheit, Ethel D. Weld, Eugenie Shieh, Jennifer C. Breakey, Pamela Hummert, Mark A. Marzinke, Brian Caffo, Craig W. Hendrix, Robert W. Buckheit, Edward J. Fuchs, Amer Al-khouja, Huan Chen, Rahul P. Bakshi
Publikováno v:
AIDS Res Hum Retroviruses
A lubricating microbicide gel designed for rectal and vaginal use would provide a behaviorally congruent strategy to enhance pre-exposure prophylaxis adherence and reduce HIV infection risk. In this study, we report the first-in-human evaluation of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e45e16087447a425cf4b0d732f46228
https://europepmc.org/articles/PMC8213010/
https://europepmc.org/articles/PMC8213010/
Autor:
Kelong Han, Kalpana Bakshi, William Spreen, Yu Lou, David A. Margolis, Craig W. Hendrix, Sharon A. Riddler, Edward J. Fuchs, Ronald D'Amico, Jafar Sadik Shaik, Susan L. Ford, Parul Patel, Stacey Edick, Ethel D. Weld, Mark A. Marzinke
Publikováno v:
British journal of clinical pharmacology. 88(4)
Aims Cabotegravir is an integrase strand transfer inhibitor in clinical development as long-acting (LA) injectable HIV preexposure prophylaxis. Methods This phase I study assessed pharmacokinetics of cabotegravir in plasma and anatomical sites associ
Autor:
Wairimu Chege, Craig W. Hendrix, Roy M. Gulick, Krista Yuhas, Kenneth H. Mayer, Ying Q. Chen, Karen L. Klingman, Marybeth McCauley, Raphael J. Landovitz, Todd T. Brown, Mark A. Marzinke, Timothy J. Wilkin
Publikováno v:
The Journal of antimicrobial chemotherapy, vol 77, iss 2
Background Tenofovir disoproxil fumarate-containing pre-exposure prophylaxis (PrEP) has been associated with decreases in bone mineral density (BMD), but the bone effects of other non-tenofovir disoproxil fumarate candidate PrEP regimens are not well
Autor:
Marybeth McCauley, Susan H. Eshleman, Vanessa Cummings, Christos J. Petropoulos, Nittaya Phanuphak, Lara E. Coelho, Maoji Li, Keren Middelkoop, Lane R. Bushman, Casey D Haines, Craig W. Hendrix, James F. Rooney, Raphael J. Landovitz, Alex R. Rinehart, Shahnaz Ahmed, Estelle Piwowar-Manning, Adeola Adeyeye, Ryan Kofron, Daniel Pryluka, Beatriz Grinsztejn, Peter L. Anderson, Brett Hanscom, Marty St. Clair, Myron S. Cohen, Jessica M. Fogel, Mark A. Marzinke, Lei Weng, Deborah Persaud, Aditya H. Gaur, Deborah Donnell
Publikováno v:
J Infect Dis
Background The HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate–emtricitabine (TDF/FTC) in preventing human immunodeficiency virus (HIV) in cisg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7456b763d6a1711fcdefa47fcd620c06
https://europepmc.org/articles/PMC8599849/
https://europepmc.org/articles/PMC8599849/